Table 1 Relevant blood investigations |
Table 1 Relevant blood
investigations |
Table 1 Relevant blood investigations |
Parameter |
Result |
Normal range |
White blood cell count |
11.1 X 109/L |
4-10 X
109/L |
Absolute neutrophil count |
9.3 X 109/L |
3-5 X
109/L |
Erythrocyte sedimentation rate |
120 mm/h |
0-15 mm/h |
C-reactive protein |
161.60 mg/L |
0-6 mg/L |
Total bilirubin |
16.47 µmol/L |
5-23 µmol/L |
Direct bilirubin |
3.39 µmol/L |
0-4 µmol/L |
Indirect bilirubin |
13.08 mol/L |
0-13 µmol/L |
Total complement |
72.20 U/mL |
23-56 U/mL |
Neuron-specific enolase |
41.47 ng/mL |
0-15.3 ng/mL |
Calcitonin |
0.88 ng/mL |
<=0.046 ng/mL |
Non-small cell carcinoma antigen |
43.91 ng/mL |
0.1-3.3
ng/mL |
Activated partial thromboplastin time |
36.7 S |
28-44S |
Fibrinogen |
5.6 g/L |
2-4 g/L |
D-dimer |
2.35 mg / L |
0-0.5 mg / L |
Anti-SSA-60 antibody |
160 U/mL |
0 U/mL |
(xMAP) Anti-SSA-52 antibody |
114 U/mL |
0 U/mL |